News | Digital Radiography (DR) | September 08, 2020

With the 510(k) clearance, practitioners can leverage dual-energy at the bed side for the first time

KA Imaging’s portable dual-energy X-ray detector has received 510(k) clearance from the U.S. Food and Drug Administration (FDA). Reveal enables bone and soft-tissue differentiation without motion artifacts in a single X-ray exposure. In other words, with one shot, the detector simultaneously delivers DR, bone and tissue images.

September 8, 2020 — KA Imaging’s portable dual-energy X-ray detector has received 510(k) clearance from the U.S. Food and Drug Administration (FDA). Reveal enables bone and soft-tissue differentiation without motion artifacts in a single X-ray exposure. In other words, with one shot, the detector simultaneously delivers DR, bone and tissue images.

“We are excited to announce the clearance of Reveal, after years of dedicated work, and we will strive to apply this technology directly to help patients and medical personnel through these trying times,” said Amol Karnick, President and CEO of KA Imaging.

The different applications for this technology include providing radiologists with unobstructed views of the lungs, which can aid in the visualization of pneumonia, fractures, catheters, and masses with high sensitivity. “The soft tissue and bone images are sharp and free of motion artifacts which increases the diagnostic sensitivity,” said Karim S. Karim, M.D., CTO of KA Imaging.

Reveal is also portable, and can be taken to the bedside of patients, which is critical during these pandemic times.

Whereas fixed dual-energy systems can cost as high as half a million dollars, KA Imaging’s Reveal is highly affordable at less than ¼ of this price.

“Any hospital can now benefit immediately from higher sensitivity X-ray imaging by simply adding dual energy capability to any installed fixed or portable X-ray machines,” said Karnick.

Clinical trials

A new clinical trial began this week in Toronto to seek early and reliable detection of pneumonia (including COVID-19).

“Early triaging is an essential countermeasure to prevent the spread of COVID-19 infection, and we are confident that our technology can make a significant contribution,” said Karim.

Reveal is also being tested on patients with lung cancer at Grand River Hospital in Kitchener, with promising results.

For more information: www.kaimaging.com


Related Content

News | Magnetic Resonance Imaging (MRI)

November 30, 2023 — Royal Philips, a global leader in health technology, today launched three new fit for purpose MR ...

Time November 30, 2023
arrow
News | Radiology Imaging

November 30, 2023 — Through its leading imaging solutions and commitment to innovation, GE HealthCare remains at the ...

Time November 30, 2023
arrow
News | RSNA

November 30, 2023 — Hologic, Inc. showcased several recent developments in next-generation AI solutions at the 109th ...

Time November 30, 2023
arrow
News | Pediatric Imaging

November 30, 2023 — Youth baseball players are prone to elbow pain and injuries, including repetitive overuse changes ...

Time November 30, 2023
arrow
News | RSNA

November 30, 2023 — Breast cancer mortality is significantly reduced when women regularly attend screening mammograms ...

Time November 30, 2023
arrow
News | Artificial Intelligence

November 29, 2023 — The Radiological Society of North America (RSNA) has announced the results of the “RSNA Abdominal ...

Time November 29, 2023
arrow
News | Artificial Intelligence

November 29, 2023 —Flywheel, a leading medical imaging artificial intelligence (AI) development platform, today ...

Time November 29, 2023
arrow
News | Contrast Media

November 29, 2023 — Bayer continues to advance its comprehensive Radiology portfolio with progress in the development ...

Time November 29, 2023
arrow
News | RSNA

November 28, 2023 — Curtis P. Langlotz, MD, PhD, has taken the helm as 2023-2024 president of the Radiological Society ...

Time November 29, 2023
arrow
News | Pediatric Imaging

November 29, 2023 — Using artificial intelligence (AI) to analyze specialized brain MRI scans of adolescents with and ...

Time November 29, 2023
arrow
Subscribe Now